US Supreme Court rejects bid to restrict access to abortion pill mifepristone

  • 📰 SkyNews
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 67%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The Supreme Court is also is expected to rule by the end of June on the legality of Idaho's strict Republican-backed abortion ban that forbids terminating a pregnancy even if necessary to protect the health of a pregnant woman facing a medical emergency.

Americans will still be able to buy an abortion pill after the US Supreme Court threw out a bid by campaign groups to restrict access to it. The decision was made by the same court that two years ago overturned Roe v Wade - which had previously given women rights to terminate a pregnancy. The drug - mifepristone - was first approved by the Food and Drug Administration in September 2000 for medical termination up to seven weeks into pregnancy, extended to 10 weeks in 2016.

US District Judge Matthew Kacsmaryk broadly sided with them in a 2023 decision that would have effectively pulled the pill off the market. Read more on Sky News:What's changed since Roe v Wade decision was overturned? However, after the FDA appealed, the New Orleans-based 5th US Circuit Court of Appeals did not go as far as Kacsmaryk but still ruled against its move to widen access to the pill. This decision was placed on hold pending the Supreme Court's review.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 35. in LAW

Law Law Latest News, Law Law Headlines